VANDA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 31 Mar 2023)
What this means for you
Registered since 13 Jun 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87230729
- Registration number
- 5222952
- Mark type
- Stylized text
- Filed
- 08 Nov 2016
- Published for opposition
- 28 Mar 2017
- Registered
- 13 Jun 2017
- Attorney of record
- Jayme M. Torelli
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in the treatment of schizophrenia; pharmaceutical preparations containing iloperidone; pharmaceutical preparations and substances for use in the treatment of circadian rhythm diseases and disorders; pharmaceutical preparations and substances for use in the treatment of non-24 hour sleep/wake disorder; and pharmaceutical preparations containing tasimelteon
Owner
- Vanda Pharmaceuticals Inc., Washington, DC, US
- Vanda Pharmaceuticals Inc., Washington, DC, US
- Vanda Pharmaceuticals Inc., Washington, DC, US
Prior registrations
Prosecution history
- 15 Sept 2026 — TEAS SECTION 8 & 9 RECEIVED
- 13 Jun 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 31 Mar 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 31 Mar 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Mar 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Sept 2022 — TEAS SECTION 8 & 15 RECEIVED
- 13 Jun 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Jun 2017 — REGISTERED-PRINCIPAL REGISTER
- 28 Mar 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Mar 2017 — PUBLISHED FOR OPPOSITION
- 08 Mar 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Feb 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Feb 2017 — ASSIGNED TO EXAMINER
- 14 Nov 2016 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 Nov 2016 — NEW APPLICATION ENTERED